Please assess the completion status of the following clinical trial:

Trial Title: A Study of Monthly Intravenous C.E.R.A. (Mircera) in Hemodialysis Participants With Chronic Renal Anemia

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Chronic renal anemia;~* Continuous intravenous maintenance erythropoietin stimulating agent (ESA) treatment during previous month;~* Regular long term hemodialysis therapy with the same mode of dialysis for \>=3 months.~Exclusion Criteria:~* Transfusion of red blood cells during previous 2 months;~* Significant acute or chronic bleeding, such as overt gastrointestinal bleeding;~* Active malignant disease (except non-melanoma skin cancer).

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- C.E.R.A. (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).